Loss of heterozygosity and methylation of p16 in renal cell carcinoma

被引:24
作者
Sanz-Casla, MT
Maestro, ML
del Barco, V
Zanna, I
Moreno, J
Vidaurreta, M
Almansa, I
Fernández, C
Blanco, J
Maestro, C [1 ]
Resel, L
机构
[1] Hosp Clin San Carlos, Lab, Dept Tumor Biol, Madrid 28040, Spain
[2] Hosp Clin San Carlos, Dept Urol, Madrid 28040, Spain
[3] Hosp Clin San Carlos, Dept Pathol, Madrid 28040, Spain
[4] Hosp Clin San Carlos, Dept Epidemiol, Madrid 28040, Spain
[5] Univ Complutense, Dept Mophol Sci, E-28040 Madrid, Spain
来源
UROLOGICAL RESEARCH | 2003年 / 31卷 / 03期
关键词
loss of heterozygosity; methylation; p16; gene; renal cell carcinoma;
D O I
10.1007/s00240-003-0308-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To investigate the possible role of genomic aberrations of chromosome 9p21 in the tumorigenesis of human renal cell carcinoma (RCC), 40 sporadic RCCs were studied using PCR analyses. The tumours were predominantly low stage and low grade. Loss of heterozygosity (LOH) was observed in nine of 39 informative cases, but no homozygous deletion was noticed. Hypermethylation of the promoter region of p16 occurred in eight of the 40 RCCs. No correlation was found between hypermethylation of the p16 gene and LOH on 9p21. A similar level of LOH and methylation was observed in the 40 RCCS regardless of histology, grade and stage. These results suggest that inactivation of p16 and the possibility of other unknown tumour suppresser genes located on other chromosomes could be involved in the pathogenesis of RCC.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 24 条
[1]   RATES OF P16(MTS1) MUTATIONS IN PRIMARY TUMORS WITH 9P LOSS [J].
CAIRNS, P ;
MAO, L ;
MERLO, A ;
LEE, DJ ;
SCHWAB, D ;
EBY, Y ;
TOKINO, K ;
VANDERRIET, P ;
BLAUGRUND, JE ;
SIDRANSKY, D .
SCIENCE, 1994, 265 (5170) :415-416
[2]   FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS [J].
CAIRNS, P ;
POLASCIK, TJ ;
EBY, Y ;
TOKINO, K ;
CALIFANO, J ;
MERLO, A ;
MAO, L ;
HERATH, J ;
JENKINS, R ;
WESTRA, W ;
RUTTER, JL ;
BUCKLER, A ;
GABRIELSON, E ;
TOCKMAN, M ;
CHO, KR ;
HEDRICK, L ;
BOVA, GS ;
ISAACS, W ;
KOCH, W ;
SCHWAB, D ;
SIDRANSKY, D .
NATURE GENETICS, 1995, 11 (02) :210-212
[3]  
CAIRNS P, 1995, CANCER RES, V55, P224
[4]  
CHENG JQ, 1994, CANCER RES, V54, P5547
[5]  
Costello JF, 1996, CANCER RES, V56, P2405
[6]   MOLECULAR-GENETIC INVESTIGATION OF SPORADIC RENAL-CELL CARCINOMA - ANALYSIS OF ALLELE LOSS ON CHROMOSOMES 3P, 5Q, 11P, 17 AND 22 [J].
FOSTER, K ;
CROSSEY, PA ;
CAIRNS, P ;
HETHERINGTON, JW ;
RICHARDS, FM ;
JONES, MH ;
BENTLEY, E ;
AFFARA, NA ;
FERGUSONSMITH, MA ;
MAHER, ER .
BRITISH JOURNAL OF CANCER, 1994, 69 (02) :230-234
[7]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[8]  
GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531
[9]  
Gonzalgo ML, 1997, CANCER RES, V57, P5336
[10]  
HERBERT J, 1994, BLOOD, V84, P4038